written on 11.03.2014
Tags:
,

AstraZeneca set for earnings boost if Ranbaxy can't deliver a Nexium generic

TAGS: ,

AstraZeneca may get lucky with Nexium. That's thanks to the embattled Ranbaxy Laboratories, the Indian generics maker that could launch a copycat version May 27.

Latest Report